Table 2.
Mediator and Pathwaya | Light-to-Moderate Smokers (<20 CPD) (n = 185) |
P for Heavy Smokers (≥20 CPD) (n = 147) | ||||
---|---|---|---|---|---|---|
P Value | Direct Effects | Indirect Effects | Total Effects | Proportion Mediated | ||
TDPV | ||||||
1b | <0.001 | 0.22 | 0.16 | 0.38 | 0.43 | 0.97 |
2c | <0.001 | 0.07 | 0.12 | 0.20 | 0.63 | 0.38 |
3d | <0.001 | 0.003 | 0.003 | 0.006 | 0.48 | 0.73 |
TDP | ||||||
1e | 0.05 | 0.29 | 0.09 | 0.38 | 0.24 | 0.63 |
2f | 0.03 | 0.12 | 0.07 | 0.20 | 0.38 | 0.21 |
3g | 0.04 | 0.004 | 0.001 | 0.006 | 0.25 | 0.40 |
Abbreviations: CPD, cigarettes per day; 3HC, trans-3′-hydroxycotinine; TDP, total daily puffs; TDPV, total daily puff volume; TSNM, total salivary nicotine metabolites.
a Square-root transformation was applied to cotinine, 3HC, TSNM, TDPV, and TDP in the mediation models.
b Pathway is CPD → TDPV → cotinine.
c Pathway is CPD → TDPV → 3HC.
d Pathway is CPD → TDPV → TSNM.
e Pathway is CPD → TDP → cotinine.
f Pathway is CPD → TDP → 3HC.
g Pathway is CPD → TDP → TSNM.